OR
Orexo AB (publ)
ORXOF · OTC
$1.44 +0.00% (+$0.00)
Market Cap 494.6M kr
P/E Ratio -
Div. Yield -
ROE 136.94%
Bulios Fair Price
$1.12
22.2% downside
Current Price
$1.44
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ORXOF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
70 /100
Cheap P/B 1.82x
P/S 3.81x
EV/FFO N/A
Growth
22 /100
Declining Book val. growth 36.15%
Rev. growth 65.37%
FCF growth N/A
Profitability
20 /100
Weak Net margin 237.89%
Op. margin 235.08%
FCF margin 1.37%
Quality
3 /100
Poor ROE 136.94%
ROA 59.95%
Asset turnover 0.25x
Debt
65 /100
Moderate Current ratio 1.65x
Int. coverage -5.71x
Debt/Equity 0.04x
Stability
36 /100
Moderate Rev. volatility 53.89%
EPS volatility 52.19%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ORXOF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Nikolaj Sorensen
Employees
65
Headquarters
Uppsala
Upcoming events
22 OCT
Earnings
Upcoming earnings report